The study by Tian et al. [29] had a dual purpose: first, to predict a PD-L1 signature (PD-L1ES) using CT images (in 939 patients), and second, to predict IO response in NSCLC patients combining PD-L1ES and clinical features (in 77 patients). This evidence concerns the gene CD274 and non-small cell lung carcinoma.